Daiichi Sankyo Company, Limited engages in the research, development, manufacture, import, sale, and marketing of pharmaceutical products. The company offers prescription drugs, OTC drugs, and quasi-drugs. Its principal products include Olmetec, Rezaltas, Calblock, and Mevalotin for cardiovascular diseases; Cravit for infectious diseases; Loxonin for bone/joint diseases; and Urief for urological diseases. The company also offers vaccines. In addition, the company is developing products for various diseases, which are under various clinical trial stages. Further, it manufactures and sells cosmetics, medical equipment, food, and beverages, as well as veterinary medicines; and manufactures active pharmaceutical ingredients and intermediates. Daiichi Sankyo primarily operates in Japan, North America, Europe, and India. The company is headquartered in Tokyo, Japan.

Daiichi Pharmaceutical Co. Ltd. manufactured pharmaceutical products. It used to make prescription drugs, OTC treatments and animal health products. The firm's prescription drugs included treatments for allergies, hypertension and stroke; it also has drugs in clinical trials. It was founded in 1915 and was located in Tokyo, Japan.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP

Lotus Pharmaceutical is a generics pharmaceutical company, founded in 1966 and headquartered in Taiwan. The company became part of the Alvogen Group in 2014, and creates high-value generic products covering CNS, CVS, oncology, female health, and anti-obesity drugs in tablets & hard/softgel capsules, for markets all across the world. The primary focus of Lotus Pharmaceutical is addressing the fast-growing market of oncology. By aligning the company’s internal development and manufacturing capabilities, the company aims to benefit patients, its employees and shareholders alike. The company is proud of its best-in-class R&D and manufacturing platform, across Taiwan and Korea. Furthermore, Lotus Pharmaceutical can reach nearly every global market with its high value pipeline through the company’s direct markets relationship with Alvogen’s commercial units spanning over 30 countries, and through alliances with top-tier pharma companies. Lotus Pharmaceutical produces and promotes a unique portfolio of high quality and difficult-to-make pharmaceutical products, and it is these products which fuels its growth. The company offers high quality and affordable generic medications that help reduce healthcare costs for people across the globe. Lotus Pharmaceutical has more than 100 strategically selected pharmaceutical projects in development and registrations across Asia and the US, as well as more than 250 products in the market. The product portfolio of Lotus Pharmaceutical focuses on high growth difficult-to-make generics in the fields of oncology, cardiology, nephrology and central nervous system disease. On top of this, Lotus Pharmaceutical sells and markets a growing portfolio of OTC (over-the-counter) medicines and will be promoting the products of its partner Alvotech – a sister company in the Alvogen Group – and their biosimilar products in Asian markets once approved. The leadership team of is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of its customers. The organisational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safely to market.

Manufactures chemicals

Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Pharmaceuticals, Information Service, and Others. The Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism. The Information Service segment offers information services to use in IT and capital investment. The Others segment includes merchandise sales and construction contractors. The company was founded on August 9, 1946 and is headquartered in Matsumoto, Japan.

Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France.

Daiichi Seiyaku Co., Ltd. engaged in the manufacture, sale research and development of medicine. The company was founded on October 1, 1915 and was headquartered in Tokyo, Japan.

Yunnan Phytopharmaceutical Co. Ltd., part of Meilleure Health International Industry Group Ltd., is a company headquartered in Kunming, China, involved in pharmaceutical preparations. On October 11, 2004 Meilleure Health International Industry Group Ltd. acquired Yunnan Phytopharmaceutical Co. Ltd. from New World Liberty China Ventures Ltd.

Ningbo Beautiful Life Med Biological Tech Co. Ltd. is a private company headquartered in China. The firm provides healthcare IT services.

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

Beijing Qi Yuan Yi De Pharmaceuticals Research Centre is a private company headquartered in Beijing, China, involved in pharmaceutical preparations.

Shenzhen Akray Electric Co., Ltd., established on 2002-06-07, Business scope includes general business items:Electrical Equipment,electronic product,Technology research and development and technical services for optical and imaging system products,On-site maintenance and sales;vehicle upholstery,vehicle interior decoration;car sales(With medical cart);Realtor,Car rental;Leasing of medical equipment;Import and export,Technology Import and Export(law,Except for items prohibited by administrative regulations;law,Projects restricted by administrative regulations must be licensed before they can be operated);Computer software technology development;Information Technology Services.,The licensing program is:one type,Class II,Class III medicalXX-ray equipment,Production and on-site maintenance of auxiliary equipment and components;Modification of special vehicles;one type,Class II,Three types of general diagnostic equipment,Medical electronic equipment,Medical Optics,Instruments and endoscopic equipment,Medical Ultrasonic Instruments and Related Equipment,Physiotherapy and Rehabilitation Equipment,medicalXX-ray equipment,medicalXX-ray accessories and components,Medical Radiation Protective Products,device,Clinical Laboratory Analytical Instruments,Medical testing and basic equipment,operating room,emergency room,Consulting room equipment and appliances,Dental equipment and appliances,purchase and sale of software.Road Motor Vehicle Production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Yamanouchi Pharmaceutical Co. Ltd. manufactures and markets drugs, quasi-drugs and medical devices. It used to promote collaboration with other pharmaceutical companies as well as bioventure companies and academia to raise the quality and speed of its R&D activities. It was founded in 1923. The company was headquartered in Tokyo, JP

Zhengzhou Sibian Technology Co., Ltd., established on 2015-11-06, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;Technology intermediary service;HR Services(Excludes job brokerage activities,Labor dispatch service);business management;Business Management Consulting;Socioeconomic Advisory Services;brand management;Conference and Exhibition Services;Safety technical training for special operators(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Manufactures and sells pharmaceuticals

Part of Sino Biopharmaceutical Ltd., Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd. is a company headquartered in Beijing, China, focused on commercial physical and biological research.

Guizhou Xinbang Far East Pharmaceutical Co., Ltd., established on 1993-08-02, Business scope includes self-production and self-sale:large volume injection,small volume injection,Freeze-dried powder injection,powder injection,(The following blank)